Key result
Procedural anticoagulation cuts radial artery occlusion ~78%, while distal transradial access shows no benefit.
Why the study?
Does procedural anticoagulation or distal transradial access reduce radial artery occlusion in patients undergoing coronary angiography?
RCT (n=439)
Open-label
2x2 factorial
No
Does procedural anticoagulation or distal transradial access reduce radial artery occlusion in patients undergoing coronary angiography?
Procedural anticoagulation, but not distal transradial access, effectively reduces the risk of radial artery occlusion in patients undergoing diagnostic coronary angiography.
Answers are grounded in this paper and cite their sources.
Procedural anticoagulation should be routine in transradial CAG to prevent RAO; confirms efficacy regardless of pre-existing oral AC while distal access adds no benefit.
BACKGROUND: Distal transradial access (TRA) and procedural anticoagulation (AC) are among the strategies to prevent radial artery occlusion (RAO) that have some gaps in evidence. AIMS: This study assessed the efficacy and safety of different radial access sites and procedural AC in patients undergoing coronary angiography (CAG). METHODS: The RAPID trial is a single-centre, open-label, 2x2 factorial study that randomised patients to procedural AC versus no procedural AC and also to distal versus conventional TRA with further stratification according to pre-existing oral AC. Patients with indicated percutaneous coronary intervention (PCI) were excluded from the analysis. The primary endpoints were the incidence of RAO, assessed by vascular ultrasound, and bleeding events. RESULTS: The trial was stopped early for efficacy by the data and safety monitoring board after the second preplanned interim analysis and inclusion of 600 participants. Excluding patients with indicated PCI, the final study population consisted of 439 patients. Distal TRA was associated with more access site crossovers (14.9% vs 8.3%; p=0.032) and a longer total procedure time (25 min vs 20 min; p=0.001) than conventional TRA. The rates of RAO (20.3% vs 21.2%; p=0.810) and bleeding events (4.1% vs 6.9%; p=0.188) were similar after distal and conventional TRA. In contrast, procedural AC reduced the incidence of RAO (7.3% vs 33.9%; p<0.001) without increasing bleeding risk (7.3% vs 3.6%; p=0.087). These results were consistent in patients on pre-existing oral AC and those with distal TRA. CONCLUSIONS: While distal TRA did not reduce the risk of RAO, procedural AC proved effective in all patients undergoing transradial CAG including those on pre-existing oral AC. (Strategies to Maintain Radial Artery Patency Following Diagnostic Coronary Angiography [RAPID] trial; ClinicalTrials.gov: NCT04301921 [RAPID-1] and NCT04362020 [RAPID-2]).
No takes yet. Share an insight, caveat, or question.
Stiermaier et al. (2025) conducted an RCT in Coronary angiography (n=439). Procedural anticoagulation and distal transradial access vs. No procedural anticoagulation and conventional transradial access was evaluated on Incidence of radial artery occlusion (RAO) and bleeding events (p=<0.001). Procedural anticoagulation reduced radial artery occlusion compared to no anticoagulation, whereas distal transradial access did not reduce occlusion risk.
Synapse has enriched 10 related papers. Consider them for comparative context: